PERPRUP 7,25 mg/mL + 633 mg/mL, solution pour application cutanée en récipient unidose

solution pour application · cutanée

Directory source checks passedOriginal source language: French

Source data retrieved: 2026-09-17. Clinical review is not yet available.

Formsolution pour application

Routecutanée

Ingredient entries2

CountryFrance

Product identity

At a glance

Authorisation holder: BECTON DICKINSON FRANCE
Authorisation status: Autorisation active
Market status: Commercialisée
Country: France
Source reference: CIS 68088932

Reported market status does not confirm current pharmacy stock.

From the official composition record

Ingredients & strength

Source entries are shown individually. An active substance (SA) and its reference moiety (FT) may describe the same ingredient; do not add their strengths together.

Source composition entries for PERPRUP 7,25 mg/mL + 633 mg/mL, solution pour application cutanée en récipient unidose
Ingredient	Strength / reference	Source role
POVIDONE IODÉEsolution	72,5 mg1 mL de solution	SAGroup 1
ALCOOL ISOPROPYLIQUEsolution	633 mg1 mL de solution	SAGroup 2

Pack references

Presentations (2)

25 ampoules en verre de 10,5 mL avec applicateurs en plastique et éponge en mousse suremballés/surpochés

CIP13 3400930279168

Présentation active · Déclaration de commercialisation

1 ampoule en verre de 26 mL avec applicateur en plastique et éponge en mousse suremballé/surpoché

CIP13 3400930279175

Présentation active · Déclaration de commercialisation

From the French medicines authority

Official documents

The official product entry provides access to the patient leaflet and professional product information when available. Documents are in French and availability varies by medicine.

Open the official product entryBDPM · CIS 68088932 · Opens in a new tab

Check the medicine name, strength and form against your pack. The authority’s current documents may be newer than the catalogue snapshot shown here.

Where this information comes from

Sources & dates

Base de données publique des médicaments (BDPM), France. Retrieval dates record when we obtained the source files; they are not clinical review dates or a guarantee of current stock.

Source files and their retrieval dates
Source file	Retrieved	Source file modified
fr_products.txt	2026-09-17	Not supplied
fr_composition.txt	2026-09-17	Not supplied
fr_packs.txt	2026-09-17	Not supplied

Directory source checks cover the factual catalogue record.Molindra clinical guidance has not yet been reviewed or published for this medicine.

Our sources and review process →